HIV and AIDS
Home HIV and AIDS
Average Premiums for Health Care Coverage Stable in 2016
Family premium 3 percent higher in 2016 than 2015; no change in share of firms offering health benefits
Importance of Drug As Assessed by Doctor Not Tied to Adherence
About 20 percent of drugs considered important by physicians were not taken correctly by patients
Recommendations Developed for Cost-Effectiveness Analyses
Concept of reference case, set of standard practices that all analyses should follow is recommended
Value-Driven Outcomes Tool Can Cut Health Care Costs
Highest variability in costs identified for post-op infection and sepsis, lowest for organ transplant
August 2016 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for August 2016. This roundup includes...
ACA Is Helping More Americans Afford Prescriptions
Improvement seen in all age levels, but millions still struggle with the cost of prescription drugs
Major Depressive Disorder Ups Acute MI Risk in HIV-Infected
HIV-infected adults with major depressive disorder have ~30 percent increased risk for AMI
Steep Rise in U.S. Drug Prices Tied to Patent Monopolies
Letting Medicare and Medicaid negotiate pricing would likely help bring costs down, researchers say
ACA Has Increased Rx Drug Use, Cut Out-of-Pocket Spending
Larger decreases in out-of-pocket spending for those who gained coverage and had chronic conditions
Legal Issues Impact Delivery of Telehealth
No uniform legal approach to telehealth; concerns about reimbursement limit implementation
